OCUL
Ocular Therapeutix, Inc.
NASDAQ · Healthcare · Biotechnology · US
$10.64
+0.00%Margins
Gross margin
87.1%
EBITDA margin
-546.7%
EBIT margin
-603.0%
Net margin
-579.1%
FCF margin
-490.1%
-58.0%
Return on equity
-44.9%
Return on assets
-52.4%
Return on invested capital
0.07x
Asset turnover
-$238.2M
Cash from operations
$2.73
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026